>Corresponding relative increases [in 2060] would be 65% (95% CI 12%; 158%) for type 1 diabetes and 673% (95% CI 362%; 1,341%) for type 2 diabetes.

There needs to be a new classification/name for type 1 diabetes. The 3% increase from 2002-2017 and the projected 65% increase among T1D can be attributed to increased detection/testing.

The fact that T1D is an autoimmune disorder while T2D is a metabolic disorder is glossed over in most studies, and the concluding statements attribute the same result for both.

>The number of youths with diabetes in the U.S. is likely to substantially increase in future decades, which emphasizes the need for prevention to attenuate this trend.

T1D has no known prevention. It is an autoimmune disorder, meaning the body attacks its own insulin-producing cells.

Perhaps one day, gene modification will make autoimmune disorders less prevalent, but we are not there yet. Prevention of T2D is an attainable goal, but the prevention of T1D is not. Combining the two is not helpful in this study.